FDA Inspection 646312 — Lannett Company, Inc.

Lannett Company, Inc. — FEI 2510865

The FDA completed an inspection of Lannett Company, Inc. on Feb 9, 2010 in Philadelphia, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 9, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Philadelphia, PA (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
139621 CFR 211.42(c)(2)Rejected Material Area
202721 CFR 211.192Investigations of discrepancies, failures
202821 CFR 211.192Extent of discrepancy, failure investigations
358521 CFR 211.110(a)Control procedures to monitor and validate performance
363921 CFR 211.204Returned drug procedures in writing and followed
364121 CFR 211.204Record information inclusions
441721 CFR 211.204Associated batches implicated, investigated

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.